Fractionated Inotuzumab Ozogamicin Combined with Low-Intensity Chemotherapy in Older Patients with Newly Diagnosed CD22+ Philadelphia Chromosome (Ph)-Negative B-Cell Precursor (BCP) Acute Lymphoblastic Leukemia (ALL): Results of the EWALL-INO StudyPatrice Chevallier, Philippe Rousselot, Michael Doubek et al.|Blood|2022Cited by 32
IL7-receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK-inhibitionLucien Courtois, Ludovic Lhermitte, Aurélie Cabannes‐Hamy et al.|Blood|2023Cited by 28